Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Oncology Drug Policies .

Tecvayli

print Print Back Back Aloxi® (palonosetron) Policy Number: VP-90008 (Intravenous)   Last Review Date:...

print Print Back Back Cabazitaxel: Jevtana®; Cabazitaxel§ Policy Number: VP-90074 (Intravenous)   Last...

print Print Back Back Provenge® (sipuleucel-T) Policy Number: VP-90100 (Intravenous)   Last Review Date:...

Kyprolis

Darzalex

print Print Back Back Portrazza™ (necitumumab) Policy Number: VP-90267 (Intravenous)   Last Review Date:...

Imlygic

print Print Back Back Sustol® (granisetron extended-release) Policy Number: VP-90283 (Subcutaneous)   Last...

Besponsa

print Print Back Back Cinvanti® (aprepitant) Policy Number: VP-90336 (Intravenous)   Last Review Date:...

print Print Back Back Akynzeo® (fosnetupitant/palonosetron) Policy Number: VP-90363 (Intravenous)   Last...

Erbitux

print Print Back Back Elzonris™ (tagraxofusp-erzs) Policy Number: VP-90426 (Intravenous)   Last Review...

print Print Back Back Reblozyl® (luspatercept-aamt) Policy Number: VP-90503 (Subcutaneous) Last Review...

Jelmyto

Breyanzi

print Print Back Back Rybrevant® (amivantamab-vmjw) Policy Number: VP-90607 (Intravenous)   Last Review...

Carvykti

Pedmark